Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid homeostasis (GO:0055089) | 9.17116502 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.39670113 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.39670113 |
4 | alpha-linolenic acid metabolic process (GO:0036109) | 6.20877735 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.09613999 |
6 | L-phenylalanine metabolic process (GO:0006558) | 6.09613999 |
7 | diacylglycerol metabolic process (GO:0046339) | 5.87792156 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78351390 |
9 | ethanol metabolic process (GO:0006067) | 5.70693146 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 5.55764535 |
11 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.51615020 |
12 | primary alcohol metabolic process (GO:0034308) | 5.33820750 |
13 | NADH metabolic process (GO:0006734) | 5.33342035 |
14 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 5.29570494 |
15 | glycerolipid catabolic process (GO:0046503) | 5.13820920 |
16 | lipid storage (GO:0019915) | 5.11226325 |
17 | regulation of triglyceride catabolic process (GO:0010896) | 5.07118434 |
18 | CDP-diacylglycerol metabolic process (GO:0046341) | 5.02395458 |
19 | brown fat cell differentiation (GO:0050873) | 4.93609132 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.88745391 |
21 | acetyl-CoA metabolic process (GO:0006084) | 4.86548890 |
22 | bile acid biosynthetic process (GO:0006699) | 4.85504401 |
23 | tryptophan catabolic process (GO:0006569) | 4.81593038 |
24 | indole-containing compound catabolic process (GO:0042436) | 4.81593038 |
25 | indolalkylamine catabolic process (GO:0046218) | 4.81593038 |
26 | biotin metabolic process (GO:0006768) | 4.80727253 |
27 | complement activation, alternative pathway (GO:0006957) | 4.79011719 |
28 | acylglycerol metabolic process (GO:0006639) | 4.73582042 |
29 | kynurenine metabolic process (GO:0070189) | 4.72957234 |
30 | urea metabolic process (GO:0019627) | 4.70069381 |
31 | urea cycle (GO:0000050) | 4.70069381 |
32 | neutral lipid metabolic process (GO:0006638) | 4.67278497 |
33 | plasma lipoprotein particle clearance (GO:0034381) | 4.65171172 |
34 | regulation of cholesterol storage (GO:0010885) | 4.63916537 |
35 | retinol metabolic process (GO:0042572) | 4.62833074 |
36 | high-density lipoprotein particle remodeling (GO:0034375) | 4.62520440 |
37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58680251 |
38 | glyoxylate metabolic process (GO:0046487) | 4.54633114 |
39 | triglyceride homeostasis (GO:0070328) | 4.54498850 |
40 | acylglycerol homeostasis (GO:0055090) | 4.54498850 |
41 | tryptophan metabolic process (GO:0006568) | 4.52433228 |
42 | fatty acid transmembrane transport (GO:1902001) | 4.50258337 |
43 | lipid particle organization (GO:0034389) | 4.48350712 |
44 | white fat cell differentiation (GO:0050872) | 4.42757980 |
45 | tricarboxylic acid metabolic process (GO:0072350) | 4.37610211 |
46 | protein carboxylation (GO:0018214) | 4.37185100 |
47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.37185100 |
48 | nitrogen cycle metabolic process (GO:0071941) | 4.34355036 |
49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.33908119 |
50 | valine metabolic process (GO:0006573) | 4.33873819 |
51 | cysteine metabolic process (GO:0006534) | 4.33830362 |
52 | regulation of sequestering of triglyceride (GO:0010889) | 4.33015299 |
53 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.30373485 |
54 | serine family amino acid catabolic process (GO:0009071) | 4.29656786 |
55 | negative regulation of fibrinolysis (GO:0051918) | 4.28678037 |
56 | lysine catabolic process (GO:0006554) | 4.28334949 |
57 | lysine metabolic process (GO:0006553) | 4.28334949 |
58 | regulation of protein activation cascade (GO:2000257) | 4.27288394 |
59 | amino-acid betaine metabolic process (GO:0006577) | 4.26584482 |
60 | bile acid metabolic process (GO:0008206) | 4.25687285 |
61 | low-density lipoprotein particle clearance (GO:0034383) | 4.25260222 |
62 | positive regulation of lipid catabolic process (GO:0050996) | 4.23707006 |
63 | oxaloacetate metabolic process (GO:0006107) | 4.23214437 |
64 | thioester biosynthetic process (GO:0035384) | 4.23196050 |
65 | acyl-CoA biosynthetic process (GO:0071616) | 4.23196050 |
66 | reverse cholesterol transport (GO:0043691) | 4.22331078 |
67 | ethanol oxidation (GO:0006069) | 4.21224827 |
68 | short-chain fatty acid metabolic process (GO:0046459) | 4.20259721 |
69 | fatty acid beta-oxidation (GO:0006635) | 4.19789038 |
70 | regulation of cholesterol esterification (GO:0010872) | 4.14446665 |
71 | polyketide metabolic process (GO:0030638) | 4.14232320 |
72 | doxorubicin metabolic process (GO:0044598) | 4.14232320 |
73 | daunorubicin metabolic process (GO:0044597) | 4.14232320 |
74 | regulation of fibrinolysis (GO:0051917) | 4.13209728 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12769248 |
76 | protein-lipid complex remodeling (GO:0034368) | 4.12769248 |
77 | macromolecular complex remodeling (GO:0034367) | 4.12769248 |
78 | tyrosine metabolic process (GO:0006570) | 4.12459467 |
79 | response to dietary excess (GO:0002021) | 4.12073252 |
80 | alpha-amino acid catabolic process (GO:1901606) | 4.08234672 |
81 | carnitine shuttle (GO:0006853) | 4.07808382 |
82 | triglyceride catabolic process (GO:0019433) | 4.07046740 |
83 | acylglycerol catabolic process (GO:0046464) | 4.03896636 |
84 | neutral lipid catabolic process (GO:0046461) | 4.03896636 |
85 | regulation of complement activation (GO:0030449) | 4.03636244 |
86 | fatty acid oxidation (GO:0019395) | 4.02388966 |
87 | cellular ketone body metabolic process (GO:0046950) | 4.00074082 |
88 | aromatic amino acid family metabolic process (GO:0009072) | 3.98624724 |
89 | lipid oxidation (GO:0034440) | 3.96565942 |
90 | phospholipid efflux (GO:0033700) | 3.95983090 |
91 | fatty acid catabolic process (GO:0009062) | 3.94282365 |
92 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.93346746 |
93 | glycerol metabolic process (GO:0006071) | 3.91341830 |
94 | positive regulation of lipid storage (GO:0010884) | 3.91111621 |
95 | coenzyme catabolic process (GO:0009109) | 3.87407769 |
96 | homocysteine metabolic process (GO:0050667) | 3.86252581 |
97 | positive regulation of fatty acid oxidation (GO:0046321) | 3.84807110 |
98 | cellular amino acid catabolic process (GO:0009063) | 3.84725985 |
99 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.84017083 |
100 | primary alcohol catabolic process (GO:0034310) | 3.81747838 |
101 | negative regulation of lipase activity (GO:0060192) | 3.81723544 |
102 | positive regulation of cholesterol efflux (GO:0010875) | 3.80551905 |
103 | branched-chain amino acid catabolic process (GO:0009083) | 3.78979752 |
104 | monocarboxylic acid catabolic process (GO:0072329) | 3.78797651 |
105 | linoleic acid metabolic process (GO:0043651) | 3.75068158 |
106 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.74506885 |
107 | phospholipid homeostasis (GO:0055091) | 3.72954675 |
108 | negative regulation of sterol transport (GO:0032372) | 3.72783812 |
109 | negative regulation of cholesterol transport (GO:0032375) | 3.72783812 |
110 | response to phenylpropanoid (GO:0080184) | 3.71658512 |
111 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68201174 |
112 | organic acid catabolic process (GO:0016054) | 3.65563955 |
113 | carboxylic acid catabolic process (GO:0046395) | 3.65563955 |
114 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.63271261 |
115 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.63268148 |
116 | acyl-CoA metabolic process (GO:0006637) | 3.62904043 |
117 | thioester metabolic process (GO:0035383) | 3.62904043 |
118 | very long-chain fatty acid metabolic process (GO:0000038) | 3.61079637 |
119 | branched-chain amino acid metabolic process (GO:0009081) | 3.59007965 |
120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58945666 |
121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58945666 |
122 | triglyceride metabolic process (GO:0006641) | 3.57821688 |
123 | phosphatidic acid biosynthetic process (GO:0006654) | 3.57644767 |
124 | phosphatidic acid metabolic process (GO:0046473) | 3.57644767 |
125 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.56052877 |
126 | fatty acid elongation (GO:0030497) | 3.55761639 |
127 | positive regulation of glycolytic process (GO:0045821) | 3.54608488 |
128 | alditol metabolic process (GO:0019400) | 3.54358451 |
129 | positive regulation of cholesterol transport (GO:0032376) | 3.54234648 |
130 | positive regulation of sterol transport (GO:0032373) | 3.54234648 |
131 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.52785758 |
132 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.52250078 |
133 | carnitine metabolic process (GO:0009437) | 3.51175119 |
134 | transcytosis (GO:0045056) | 3.49747298 |
135 | triglyceride biosynthetic process (GO:0019432) | 3.49054693 |
136 | cholesterol efflux (GO:0033344) | 3.48607454 |
137 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.45928878 |
138 | neutral lipid biosynthetic process (GO:0046460) | 3.44457127 |
139 | acylglycerol biosynthetic process (GO:0046463) | 3.44457127 |
140 | glutamate metabolic process (GO:0006536) | 3.44297111 |
141 | ketone body metabolic process (GO:1902224) | 3.44256755 |
142 | bile acid and bile salt transport (GO:0015721) | 3.43269898 |
143 | protein heterotrimerization (GO:0070208) | 3.40105474 |
144 | regulation of cholesterol transport (GO:0032374) | 3.37129631 |
145 | regulation of sterol transport (GO:0032371) | 3.37129631 |
146 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.31284593 |
147 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.25683856 |
148 | L-serine transport (GO:0015825) | 3.19201723 |
149 | regulation of lipid catabolic process (GO:0050994) | 3.15286831 |
150 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.14914984 |
151 | positive regulation of glomerulus development (GO:0090193) | 3.13975104 |
152 | polyol transport (GO:0015791) | 3.10628608 |
153 | negative regulation of lipid catabolic process (GO:0050995) | 3.10101682 |
154 | regulation of lipid storage (GO:0010883) | 3.03979511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.32017490 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.38765229 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.29972720 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89184264 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.60558904 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.79721039 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08940589 |
8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79634011 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.56399783 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.07571448 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.63384001 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1205499 |
13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92314343 |
14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66149693 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64873949 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60595692 |
17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50353004 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43441544 |
19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29897170 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25489813 |
21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21281450 |
22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21044244 |
23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20403103 |
24 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15076181 |
25 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10674622 |
26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08568477 |
27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07732124 |
28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06988273 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04473556 |
30 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00608125 |
31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00396900 |
32 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99788394 |
33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99643532 |
34 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98301788 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97118515 |
36 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.95312034 |
37 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95234853 |
38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93447404 |
39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93001153 |
40 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92379597 |
41 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91066675 |
42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87298811 |
43 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84682353 |
44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84076012 |
45 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.83435569 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83245226 |
47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82824311 |
48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82026005 |
49 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81830037 |
50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81758853 |
51 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81214732 |
52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81003893 |
53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81003893 |
54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80960352 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79979459 |
56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79060830 |
57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77614447 |
58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.76914739 |
59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.76914739 |
60 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.75774730 |
61 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.75722078 |
62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74979736 |
63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74522136 |
64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72363614 |
65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72262901 |
66 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.71650806 |
67 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70926138 |
68 | P68_20966046_ChIP-Seq_HELA_Human | 0.70432582 |
69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69885672 |
70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69859067 |
71 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.69698662 |
72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68244106 |
73 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68069615 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68060350 |
75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67257358 |
76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67188419 |
77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.67046552 |
78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66984936 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66916919 |
80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66776200 |
81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.66696950 |
82 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.66581637 |
83 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.65785416 |
84 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.64504522 |
85 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.64376066 |
86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63316730 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62808002 |
88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.62722893 |
89 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.62549038 |
90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.62394779 |
91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62359371 |
92 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.62278723 |
93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61296421 |
94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60864250 |
95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60183753 |
96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60183753 |
97 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.59824078 |
98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.57863353 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57848253 |
100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.57773483 |
101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.57256624 |
102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57023087 |
103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56483247 |
104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55972729 |
105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.55791669 |
106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54081188 |
107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53613938 |
108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.53512422 |
109 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53247729 |
110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53112998 |
111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.53097673 |
112 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.52298195 |
113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51890336 |
114 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51330896 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51312202 |
116 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.50024811 |
117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.49681675 |
118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48599514 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.47293563 |
120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.46531838 |
121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.45927019 |
122 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45513113 |
123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45454631 |
124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.45428452 |
125 | AR_20517297_ChIP-Seq_VCAP_Human | 0.45265085 |
126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.44935558 |
127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44774257 |
128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.43943060 |
129 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43832354 |
130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.43619847 |
131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.43455974 |
132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43087757 |
133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43077188 |
134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41942643 |
135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41847999 |
136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41600857 |
137 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.41100621 |
138 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.41100621 |
139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40746087 |
140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.40552755 |
141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.39567015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.44192321 |
2 | MP0005360_urolithiasis | 6.44991158 |
3 | MP0005365_abnormal_bile_salt | 5.55256184 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.36160887 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.28364038 |
6 | MP0010329_abnormal_lipoprotein_level | 3.98734005 |
7 | MP0005670_abnormal_white_adipose | 3.50582440 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.39970445 |
9 | MP0003252_abnormal_bile_duct | 3.23695487 |
10 | MP0009840_abnormal_foam_cell | 2.88551284 |
11 | MP0005332_abnormal_amino_acid | 2.64408928 |
12 | MP0005083_abnormal_biliary_tract | 2.59017890 |
13 | * MP0002118_abnormal_lipid_homeostasis | 2.56186750 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.46751790 |
15 | MP0004130_abnormal_muscle_cell | 2.39480640 |
16 | MP0005666_abnormal_adipose_tissue | 2.29095955 |
17 | MP0000609_abnormal_liver_physiology | 2.28908424 |
18 | MP0001666_abnormal_nutrient_absorption | 2.20410121 |
19 | MP0003195_calcinosis | 2.05361133 |
20 | MP0004019_abnormal_vitamin_homeostasis | 2.00181801 |
21 | MP0002971_abnormal_brown_adipose | 1.86844543 |
22 | MP0005319_abnormal_enzyme/_coenzyme | 1.80860381 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.76095132 |
24 | MP0004185_abnormal_adipocyte_glucose | 1.72069329 |
25 | MP0001764_abnormal_homeostasis | 1.63894450 |
26 | MP0002876_abnormal_thyroid_physiology | 1.60833266 |
27 | MP0005334_abnormal_fat_pad | 1.55391405 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 1.53903015 |
29 | MP0003186_abnormal_redox_activity | 1.52144135 |
30 | MP0003011_delayed_dark_adaptation | 1.51664583 |
31 | MP0002254_reproductive_system_inflammat | 1.49823445 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.48335339 |
33 | MP0003868_abnormal_feces_composition | 1.41832023 |
34 | MP0005375_adipose_tissue_phenotype | 1.40003430 |
35 | MP0003828_pulmonary_edema | 1.34374011 |
36 | MP0005535_abnormal_body_temperature | 1.33592646 |
37 | MP0003705_abnormal_hypodermis_morpholog | 1.29524507 |
38 | MP0000343_altered_response_to | 1.25025480 |
39 | MP0003690_abnormal_glial_cell | 1.23794995 |
40 | MP0009643_abnormal_urine_homeostasis | 1.23583028 |
41 | MP0005503_abnormal_tendon_morphology | 1.23322878 |
42 | MP0005647_abnormal_sex_gland | 1.22289468 |
43 | MP0009115_abnormal_fat_cell | 1.20573608 |
44 | * MP0001881_abnormal_mammary_gland | 1.19354406 |
45 | MP0002909_abnormal_adrenal_gland | 1.18786590 |
46 | MP0001661_extended_life_span | 1.18677496 |
47 | MP0002078_abnormal_glucose_homeostasis | 1.18489084 |
48 | MP0009697_abnormal_copulation | 1.18199649 |
49 | MP0005379_endocrine/exocrine_gland_phen | 1.17837946 |
50 | MP0006036_abnormal_mitochondrial_physio | 1.15977931 |
51 | MP0000751_myopathy | 1.15748593 |
52 | MP0000604_amyloidosis | 1.09377245 |
53 | MP0008438_abnormal_cutaneous_collagen | 1.08424031 |
54 | MP0002970_abnormal_white_adipose | 1.06892311 |
55 | MP0005448_abnormal_energy_balance | 1.04820608 |
56 | MP0000598_abnormal_liver_morphology | 1.04158196 |
57 | MP0005451_abnormal_body_composition | 1.01908198 |
58 | MP0003279_aneurysm | 0.99077414 |
59 | MP0009763_increased_sensitivity_to | 0.97033672 |
60 | MP0005385_cardiovascular_system_phenoty | 0.94834775 |
61 | MP0001544_abnormal_cardiovascular_syste | 0.94834775 |
62 | MP0003656_abnormal_erythrocyte_physiolo | 0.93274069 |
63 | MP0009764_decreased_sensitivity_to | 0.87049094 |
64 | MP0003950_abnormal_plasma_membrane | 0.86413642 |
65 | MP0003948_abnormal_gas_homeostasis | 0.84903243 |
66 | MP0003329_amyloid_beta_deposits | 0.84278498 |
67 | MP0009642_abnormal_blood_homeostasis | 0.83992525 |
68 | MP0002108_abnormal_muscle_morphology | 0.79899395 |
69 | MP0005376_homeostasis/metabolism_phenot | 0.77483638 |
70 | MP0004272_abnormal_basement_membrane | 0.77094532 |
71 | MP0005636_abnormal_mineral_homeostasis | 0.73973888 |
72 | MP0002638_abnormal_pupillary_reflex | 0.73722778 |
73 | MP0010368_abnormal_lymphatic_system | 0.73228030 |
74 | MP0008469_abnormal_protein_level | 0.72779986 |
75 | MP0003959_abnormal_lean_body | 0.72168793 |
76 | MP0000013_abnormal_adipose_tissue | 0.70455088 |
77 | MP0003724_increased_susceptibility_to | 0.69466384 |
78 | MP0001756_abnormal_urination | 0.68991415 |
79 | MP0005501_abnormal_skin_physiology | 0.68369444 |
80 | MP0005452_abnormal_adipose_tissue | 0.67870184 |
81 | MP0003953_abnormal_hormone_level | 0.66177378 |
82 | MP0004087_abnormal_muscle_fiber | 0.65776271 |
83 | MP0002796_impaired_skin_barrier | 0.64737949 |
84 | MP0000759_abnormal_skeletal_muscle | 0.64389438 |
85 | MP0000003_abnormal_adipose_tissue | 0.64353124 |
86 | MP0005275_abnormal_skin_tensile | 0.64122702 |
87 | MP0006276_abnormal_autonomic_nervous | 0.61775993 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.61485138 |
89 | MP0005266_abnormal_metabolism | 0.60519089 |
90 | MP0004381_abnormal_hair_follicle | 0.59399716 |
91 | MP0001944_abnormal_pancreas_morphology | 0.58151272 |
92 | MP0004215_abnormal_myocardial_fiber | 0.57794129 |
93 | MP0000858_altered_metastatic_potential | 0.56179460 |
94 | MP0000639_abnormal_adrenal_gland | 0.54476324 |
95 | MP0008775_abnormal_heart_ventricle | 0.53405949 |
96 | MP0005084_abnormal_gallbladder_morpholo | 0.52855569 |
97 | MP0008872_abnormal_physiological_respon | 0.52551816 |
98 | MP0001853_heart_inflammation | 0.52148997 |
99 | MP0002295_abnormal_pulmonary_circulatio | 0.51464014 |
100 | MP0001177_atelectasis | 0.51414595 |
101 | MP0000749_muscle_degeneration | 0.50783569 |
102 | MP0003075_altered_response_to | 0.50474713 |
103 | MP0001958_emphysema | 0.47828522 |
104 | MP0004782_abnormal_surfactant_physiolog | 0.47702465 |
105 | MP0000230_abnormal_systemic_arterial | 0.47518463 |
106 | MP0000767_abnormal_smooth_muscle | 0.47256578 |
107 | MP0003879_abnormal_hair_cell | 0.46985147 |
108 | MP0002168_other_aberrant_phenotype | 0.46663761 |
109 | MP0005164_abnormal_response_to | 0.45764685 |
110 | MP0002060_abnormal_skin_morphology | 0.45369927 |
111 | MP0006035_abnormal_mitochondrial_morpho | 0.45118484 |
112 | MP0002090_abnormal_vision | 0.44841794 |
113 | MP0005395_other_phenotype | 0.43786035 |
114 | MP0008874_decreased_physiological_sensi | 0.43508704 |
115 | MP0002136_abnormal_kidney_physiology | 0.43101930 |
116 | MP0005220_abnormal_exocrine_pancreas | 0.42763769 |
117 | MP0002933_joint_inflammation | 0.42679761 |
118 | MP0009672_abnormal_birth_weight | 0.42252453 |
119 | MP0005408_hypopigmentation | 0.39904811 |
120 | MP0000249_abnormal_blood_vessel | 0.38643857 |
121 | MP0002332_abnormal_exercise_endurance | 0.38385334 |
122 | MP0000427_abnormal_hair_cycle | 0.37329519 |
123 | MP0003638_abnormal_response/metabolism_ | 0.36708932 |
124 | MP0006138_congestive_heart_failure | 0.36696068 |
125 | MP0005595_abnormal_vascular_smooth | 0.36129545 |
126 | MP0009780_abnormal_chondrocyte_physiolo | 0.35516056 |
127 | MP0005167_abnormal_blood-brain_barrier | 0.34338554 |
128 | MP0004147_increased_porphyrin_level | 0.33992039 |
129 | MP0002069_abnormal_eating/drinking_beha | 0.31721880 |
130 | MP0004883_abnormal_blood_vessel | 0.31599235 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.26350393 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.18036774 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.88094952 |
4 | Xanthomatosis (HP:0000991) | 5.81050082 |
5 | Hyperlipoproteinemia (HP:0010980) | 5.51156834 |
6 | Hyperglycinuria (HP:0003108) | 5.41069408 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.31769291 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.25033050 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.23724359 |
10 | Complement deficiency (HP:0004431) | 5.08143661 |
11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.06425280 |
12 | Abnormality of glycine metabolism (HP:0010895) | 5.06425280 |
13 | Hyperglycinemia (HP:0002154) | 4.92719233 |
14 | Hyperammonemia (HP:0001987) | 4.82234690 |
15 | Increased serum pyruvate (HP:0003542) | 4.77234467 |
16 | Ketosis (HP:0001946) | 4.75527403 |
17 | Hypolipoproteinemia (HP:0010981) | 4.49585395 |
18 | Hypoglycemic coma (HP:0001325) | 4.47060370 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.39946045 |
20 | Epidermoid cyst (HP:0200040) | 4.39025451 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.28854097 |
22 | Abnormality of glycolysis (HP:0004366) | 4.22405425 |
23 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.04486318 |
24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.94251275 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.93936642 |
26 | Ketoacidosis (HP:0001993) | 3.88051673 |
27 | Joint hemorrhage (HP:0005261) | 3.81455268 |
28 | Protrusio acetabuli (HP:0003179) | 3.72478879 |
29 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.72447821 |
30 | Abnormality of complement system (HP:0005339) | 3.60738123 |
31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.54392238 |
32 | Abnormality of alanine metabolism (HP:0010916) | 3.54392238 |
33 | Hyperalaninemia (HP:0003348) | 3.54392238 |
34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51608920 |
35 | Hypercholesterolemia (HP:0003124) | 3.49350079 |
36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.48761881 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.45418765 |
38 | Abnormality of methionine metabolism (HP:0010901) | 3.40416698 |
39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39395709 |
40 | Abnormal hemoglobin (HP:0011902) | 3.33909061 |
41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.27801171 |
42 | Dicarboxylic aciduria (HP:0003215) | 3.27801171 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 3.26975659 |
44 | Fat malabsorption (HP:0002630) | 3.23820512 |
45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13104674 |
46 | Growth hormone excess (HP:0000845) | 3.09871837 |
47 | Hypertriglyceridemia (HP:0002155) | 2.99973581 |
48 | Bone cyst (HP:0012062) | 2.98196143 |
49 | Long foot (HP:0001833) | 2.92829457 |
50 | Myocardial infarction (HP:0001658) | 2.91893248 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.90564929 |
52 | Delayed CNS myelination (HP:0002188) | 2.88963923 |
53 | Vertebral compression fractures (HP:0002953) | 2.88441929 |
54 | Difficulty running (HP:0009046) | 2.87866052 |
55 | Lethargy (HP:0001254) | 2.85861094 |
56 | Metabolic acidosis (HP:0001942) | 2.84393287 |
57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82924014 |
58 | Infantile muscular hypotonia (HP:0008947) | 2.81621404 |
59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.81583462 |
60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80695870 |
61 | Hypercortisolism (HP:0001578) | 2.79994281 |
62 | Hyperbilirubinemia (HP:0002904) | 2.79143834 |
63 | Skin nodule (HP:0200036) | 2.78045323 |
64 | Abnormality of proline metabolism (HP:0010907) | 2.74577031 |
65 | Hydroxyprolinuria (HP:0003080) | 2.74577031 |
66 | Hypoglycemic seizures (HP:0002173) | 2.71060367 |
67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.67642183 |
68 | Oligomenorrhea (HP:0000876) | 2.62463500 |
69 | Rickets (HP:0002748) | 2.59077711 |
70 | Cerebral edema (HP:0002181) | 2.58720269 |
71 | Back pain (HP:0003418) | 2.58360533 |
72 | Systemic lupus erythematosus (HP:0002725) | 2.56738034 |
73 | Abnormal eating behavior (HP:0100738) | 2.56475553 |
74 | Polyphagia (HP:0002591) | 2.50482224 |
75 | Ileus (HP:0002595) | 2.50198146 |
76 | Pancreatitis (HP:0001733) | 2.48673823 |
77 | Steatorrhea (HP:0002570) | 2.46676876 |
78 | Polycythemia (HP:0001901) | 2.45700961 |
79 | Myoglobinuria (HP:0002913) | 2.44903056 |
80 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.44412521 |
81 | Hepatocellular carcinoma (HP:0001402) | 2.39947461 |
82 | Acanthosis nigricans (HP:0000956) | 2.39782502 |
83 | Axonal loss (HP:0003447) | 2.37140831 |
84 | Brushfield spots (HP:0001088) | 2.33458063 |
85 | Hemorrhage of the eye (HP:0011885) | 2.33388613 |
86 | Generalized aminoaciduria (HP:0002909) | 2.32673895 |
87 | Abnormal gallbladder morphology (HP:0012437) | 2.30742602 |
88 | Vomiting (HP:0002013) | 2.30349239 |
89 | Hypophosphatemic rickets (HP:0004912) | 2.25375501 |
90 | Cholelithiasis (HP:0001081) | 2.24876774 |
91 | Irritability (HP:0000737) | 2.23258787 |
92 | Amyloidosis (HP:0011034) | 2.22014466 |
93 | Abnormal gallbladder physiology (HP:0012438) | 2.19183517 |
94 | Cholecystitis (HP:0001082) | 2.19183517 |
95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.18606057 |
96 | Vascular calcification (HP:0004934) | 2.15199943 |
97 | Ectopia lentis (HP:0001083) | 2.13421372 |
98 | Gout (HP:0001997) | 2.12439035 |
99 | Hyperglycemia (HP:0003074) | 2.11691303 |
100 | Premature rupture of membranes (HP:0001788) | 2.10986399 |
101 | Abnormal cartilage morphology (HP:0002763) | 2.10410722 |
102 | Spastic diplegia (HP:0001264) | 2.10310530 |
103 | Prominent supraorbital ridges (HP:0000336) | 2.10245774 |
104 | Hypochromic microcytic anemia (HP:0004840) | 2.07612587 |
105 | Spontaneous abortion (HP:0005268) | 2.07582456 |
106 | Renal cortical cysts (HP:0000803) | 2.07131708 |
107 | Subcapsular cataract (HP:0000523) | 2.04529699 |
108 | Increased muscle lipid content (HP:0009058) | 2.01281583 |
109 | Neonatal onset (HP:0003623) | 2.00975328 |
110 | Late onset (HP:0003584) | 2.00640738 |
111 | Sensorimotor neuropathy (HP:0007141) | 1.99959258 |
112 | Mitral stenosis (HP:0001718) | 1.99130309 |
113 | Cardiovascular calcification (HP:0011915) | 1.98231123 |
114 | Abnormality of the periventricular white matter (HP:0002518) | 1.97553515 |
115 | Acanthocytosis (HP:0001927) | 1.97230663 |
116 | Enlarged kidneys (HP:0000105) | 1.96329799 |
117 | Esophageal varix (HP:0002040) | 1.96105351 |
118 | Nausea (HP:0002018) | 1.95761580 |
119 | Rhabdomyolysis (HP:0003201) | 1.93199928 |
120 | Hepatosplenomegaly (HP:0001433) | 1.91752395 |
121 | Neonatal hypoglycemia (HP:0001998) | 1.90435936 |
122 | Glomerulonephritis (HP:0000099) | 1.89866589 |
123 | Insulin resistance (HP:0000855) | 1.87799636 |
124 | Elevated hepatic transaminases (HP:0002910) | 1.87033837 |
125 | Opisthotonus (HP:0002179) | 1.86273304 |
126 | Increased purine levels (HP:0004368) | 1.84561044 |
127 | Hyperuricemia (HP:0002149) | 1.84561044 |
128 | Increased mean platelet volume (HP:0011877) | 1.80577199 |
129 | Methylmalonic aciduria (HP:0012120) | 1.80437291 |
130 | Lymphangioma (HP:0100764) | 1.79390397 |
131 | Proximal tubulopathy (HP:0000114) | 1.79246726 |
132 | Abnormality of the gallbladder (HP:0005264) | 1.79229055 |
133 | Pigmentary retinal degeneration (HP:0001146) | 1.79129450 |
134 | Hepatic necrosis (HP:0002605) | 1.78946925 |
135 | Symptomatic seizures (HP:0011145) | 1.78608190 |
136 | Nephritis (HP:0000123) | 1.78228036 |
137 | Renal Fanconi syndrome (HP:0001994) | 1.77890813 |
138 | Accelerated skeletal maturation (HP:0005616) | 1.77767365 |
139 | Polygenic inheritance (HP:0010982) | 1.74919642 |
140 | Conjunctival hamartoma (HP:0100780) | 1.73799626 |
141 | Multiple lipomas (HP:0001012) | 1.73552272 |
142 | Atrioventricular block (HP:0001678) | 1.72477519 |
143 | Gowers sign (HP:0003391) | 1.71697388 |
144 | Polar cataract (HP:0010696) | 1.69834979 |
145 | Spinal rigidity (HP:0003306) | 1.69579867 |
146 | Epiphyseal stippling (HP:0010655) | 1.67900696 |
147 | Cerebral inclusion bodies (HP:0100314) | 1.67346597 |
148 | Hyperparathyroidism (HP:0000843) | 1.67295094 |
149 | Lipoatrophy (HP:0100578) | 1.67085394 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.51455827 |
2 | SIK1 | 5.87945234 |
3 | CAMK1D | 5.10875376 |
4 | TRIB3 | 3.64608963 |
5 | CAMK1G | 3.63825049 |
6 | ERN1 | 3.29118838 |
7 | FGFR4 | 2.71918543 |
8 | INSRR | 2.55183853 |
9 | TESK1 | 2.53289929 |
10 | DDR2 | 2.42669041 |
11 | ARAF | 2.38343913 |
12 | PDK4 | 2.26615128 |
13 | PDK3 | 2.26615128 |
14 | PKN2 | 2.14280371 |
15 | PRKAA2 | 1.93901007 |
16 | MST1R | 1.84612055 |
17 | PRPF4B | 1.55539053 |
18 | GRK5 | 1.47452567 |
19 | MAP2K4 | 1.47220772 |
20 | ERBB4 | 1.47142874 |
21 | FGFR2 | 1.42624259 |
22 | LATS1 | 1.40157267 |
23 | CAMKK2 | 1.37127880 |
24 | MAPKAPK3 | 1.35493051 |
25 | FLT3 | 1.33744050 |
26 | PDK2 | 1.32684945 |
27 | RIPK1 | 1.32359390 |
28 | MAPK11 | 1.32037798 |
29 | FRK | 1.29006355 |
30 | PIM2 | 1.28736271 |
31 | TIE1 | 1.14291819 |
32 | TAOK3 | 1.12873733 |
33 | DAPK2 | 1.11685408 |
34 | PIK3CG | 1.11545124 |
35 | ILK | 1.11309796 |
36 | NEK9 | 1.06011516 |
37 | PINK1 | 1.05925017 |
38 | LMTK2 | 1.04659663 |
39 | PIK3CA | 1.02467629 |
40 | PRKAA1 | 0.99447488 |
41 | PTK6 | 0.98640131 |
42 | JAK2 | 0.97321382 |
43 | JAK1 | 0.94169052 |
44 | ADRBK1 | 0.93527720 |
45 | TGFBR2 | 0.91892141 |
46 | MAP3K7 | 0.90773372 |
47 | MOS | 0.90337307 |
48 | FGFR3 | 0.85130548 |
49 | TYK2 | 0.84388022 |
50 | ABL2 | 0.83201447 |
51 | IRAK3 | 0.83089030 |
52 | RIPK4 | 0.83024688 |
53 | MET | 0.82365037 |
54 | MAPK12 | 0.81530520 |
55 | LRRK2 | 0.81306247 |
56 | KDR | 0.81304888 |
57 | EEF2K | 0.80964597 |
58 | PRKACG | 0.79305100 |
59 | CDK6 | 0.77472420 |
60 | PDPK1 | 0.73389376 |
61 | GSK3A | 0.70352086 |
62 | MAP2K1 | 0.67525111 |
63 | SCYL2 | 0.65940588 |
64 | NLK | 0.64315687 |
65 | MAPK4 | 0.63267438 |
66 | RET | 0.62969802 |
67 | STK38L | 0.62589067 |
68 | PRKCZ | 0.62432036 |
69 | MAPK3 | 0.61901205 |
70 | DAPK3 | 0.60645641 |
71 | EPHB1 | 0.58913128 |
72 | MAP2K3 | 0.58176591 |
73 | IGF1R | 0.57914594 |
74 | PHKG1 | 0.56627747 |
75 | PHKG2 | 0.56627747 |
76 | PDK1 | 0.53493898 |
77 | SGK3 | 0.52045567 |
78 | TBK1 | 0.51277433 |
79 | MAP3K6 | 0.49977282 |
80 | GRK6 | 0.48909636 |
81 | PAK2 | 0.48739902 |
82 | KSR2 | 0.47631284 |
83 | MAP3K14 | 0.47099428 |
84 | BRAF | 0.46750139 |
85 | PRKG1 | 0.46631271 |
86 | EPHA3 | 0.46542291 |
87 | CAMKK1 | 0.43481545 |
88 | MAP3K3 | 0.43294823 |
89 | MYLK | 0.43028578 |
90 | TYRO3 | 0.42947077 |
91 | PDGFRA | 0.42806578 |
92 | CSK | 0.42452046 |
93 | SGK494 | 0.42361743 |
94 | SGK223 | 0.42361743 |
95 | CDK9 | 0.41550367 |
96 | ABL1 | 0.40768457 |
97 | MTOR | 0.40530495 |
98 | PDGFRB | 0.39913490 |
99 | CAMK1 | 0.39690666 |
100 | KIT | 0.38409890 |
101 | SGK2 | 0.38017846 |
102 | PAK1 | 0.37608239 |
103 | IRAK1 | 0.37391862 |
104 | PKN1 | 0.36747426 |
105 | CAMK2G | 0.36371816 |
106 | EPHB2 | 0.36251796 |
107 | TRPM7 | 0.36192937 |
108 | PRKD1 | 0.34392482 |
109 | CSF1R | 0.34381434 |
110 | FER | 0.34341792 |
111 | EIF2AK2 | 0.33201986 |
112 | MAPK7 | 0.32843560 |
113 | YES1 | 0.32790826 |
114 | MAPKAPK5 | 0.32744848 |
115 | AKT2 | 0.32139360 |
116 | DYRK1B | 0.31720200 |
117 | LATS2 | 0.31595553 |
118 | RPS6KA3 | 0.31199393 |
119 | MAP3K13 | 0.31091693 |
120 | FGFR1 | 0.30034267 |
121 | STK16 | 0.29734392 |
122 | CDK4 | 0.29555151 |
123 | ERBB2 | 0.29314347 |
124 | PRKCH | 0.29273638 |
125 | MAP2K6 | 0.27232648 |
126 | SRC | 0.27009152 |
127 | ZAP70 | 0.26839816 |
128 | IRAK2 | 0.26182803 |
129 | PRKACA | 0.25106109 |
130 | EPHA4 | 0.25050195 |
131 | BMX | 0.23988665 |
132 | PRKACB | 0.23259427 |
133 | CSNK1G1 | 0.23050017 |
134 | PRKCQ | 0.22907825 |
135 | PTK2 | 0.22735565 |
136 | TNK2 | 0.21876197 |
137 | STK38 | 0.20938222 |
138 | JAK3 | 0.20319504 |
139 | PTK2B | 0.19695714 |
140 | INSR | 0.19560779 |
141 | PRKCA | 0.18627046 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70146586 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33666179 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.00959164 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93394500 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89540109 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.89287080 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78820892 |
8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.71520325 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70653151 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59280878 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.58603618 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55045980 |
13 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.47399716 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42204007 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21196949 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19178135 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12826966 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11273573 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.10616348 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.01197545 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97778740 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94003728 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88613612 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82782849 |
25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70075034 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69264272 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68950375 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60243526 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57330128 |
30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54584414 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53715052 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50848631 |
33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50701738 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50598477 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47097571 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44975149 |
37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42557680 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41030733 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36970589 |
40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34015118 |
41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.29790912 |
42 | Bile secretion_Homo sapiens_hsa04976 | 1.26000851 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23658354 |
44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22519708 |
45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20094169 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17557715 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08314989 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.06153849 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02444665 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00211311 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97470582 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95990911 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94349532 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85832364 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81067794 |
56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78466376 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77659804 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.74814785 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74496341 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73709039 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72841711 |
62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67784753 |
63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64643919 |
64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61371934 |
65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61278870 |
66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55618115 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54354865 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.48776609 |
69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48417209 |
70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46549900 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38120560 |
72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37993982 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37036262 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36334866 |
75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36139034 |
76 | Renin secretion_Homo sapiens_hsa04924 | 0.27941334 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27136520 |
78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24822329 |
79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24425372 |
80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24394192 |
81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22751996 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22333038 |
83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17260082 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.16672423 |
85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07468919 |
86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07411413 |
87 | Malaria_Homo sapiens_hsa05144 | 0.04400024 |
88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2279008 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2181676 |
90 | Amoebiasis_Homo sapiens_hsa05146 | -0.2156982 |
91 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2126402 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2111993 |
93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2010360 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1936057 |
95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1876219 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1857218 |
97 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1633973 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1450670 |
99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.1330295 |
100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1227247 |
101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1226430 |
102 | Pertussis_Homo sapiens_hsa05133 | -0.1205796 |
103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1159527 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1076215 |
105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0858103 |
106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0802897 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0714536 |
108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0683921 |
109 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0638915 |
110 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0622178 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0496519 |
112 | Focal adhesion_Homo sapiens_hsa04510 | -0.0410893 |
113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0398496 |
114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0091716 |